INDIANAPOLIS (AP) — A top cancer researcher is leaving Indiana University to move to Silicon Valley to continue his research into the causes of cancer.
WISH-TV reports (http://bit.ly/VX9IRN ) Dr. George Sledge will leave IU in December to become chief of oncology at Stanford University's Department of Medicine.
Sledge is co-director of the breast cancer program at the IU Cancer Center. He is widely published and has chaired several clinical trials involving new treatments.
At IU, he developed a drug called paclitaxel for the treatment of metastatic breast cancer and explored ways to combine it with other medications for more effective treatment.
Sledge says targeting cancer in such ways can bring better cure rates and fewer side effects.
Information from: WISH-TV, http://www.wishtv.com/